Pressure BioSciences, Inc.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a PBIO research report →
Companywww.pressurebiosciences.com
Pressure BioSciences, Inc. develops and sells pressure-based platform solutions in the North America, Europe, and Asia. The company's pressure cycling technology (PCT) technology uses alternating cycles of hydrostatic pressure between ambient and ultra-high levels to control the actions of molecules in biological samples, including cells and tissues from human, animal, plant, and microbial sources.
- CEO
- Richard T. Schumacher
- IPO
- 1996
- Employees
- 15
- HQ
- Canton, MA, US
Price Chart
Valuation
- Market Cap
- $24.58K
- P/E
- -0.00
- P/S
- 0.01
- P/B
- -0.00
- EV/EBITDA
- -2.43
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 40.43%
- Op Margin
- -480.51%
- Net Margin
- -1482.19%
- ROE
- 89.59%
- ROIC
- 96.35%
Growth & Income
- Revenue
- $1.98M · 14.36%
- Net Income
- $-29,314,298 · -82.34%
- EPS
- $-1.51 · 6.21%
- Op Income
- $-9,503,358
- FCF YoY
- 29.01%
Performance & Tape
- 52W High
- $0.20
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.00
- Beta
- 6.21
- Avg Volume
- 5.82K
Get TickerSpark's AI analysis on PBIO
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| Sep 27, 24 | PETERSON JEFFREY N | other | 59,652 |
| Sep 27, 24 | SCHUMACHER RICHARD T | other | 22,878 |
| Sep 27, 24 | Urdea Michael S | other | 14,429 |
| Sep 27, 24 | Lazarev Alexander V | other | 18,863 |
| Mar 27, 24 | Urdea Michael S | other | 2,872 |
| Mar 27, 24 | SCHUMACHER RICHARD T | other | 4,554 |
| Mar 27, 24 | Pollack Kevin | other | 2,914 |
| Mar 27, 24 | PETERSON JEFFREY N | other | 11,874 |
| Mar 27, 24 | Mangiardi Vito J | other | 625 |
| Mar 27, 24 | Lazarev Alexander V | other | 3,755 |
Our PBIO Coverage
We haven't published any research on PBIO yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate PBIO Report →